These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 24480974)
1. Pulmonary medication adherence and health-care use in cystic fibrosis. Quittner AL; Zhang J; Marynchenko M; Chopra PA; Signorovitch J; Yushkina Y; Riekert KA Chest; 2014 Jul; 146(1):142-151. PubMed ID: 24480974 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity? Hatziagorou E; Manika K; Kyrvasili SS; Kotoulas SC; Chrysochoou EA; Kouroukli E; Sionidou M; Tsanakas J Pediatr Pulmonol; 2022 Dec; 57(12):3017-3026. PubMed ID: 35997065 [TBL] [Abstract][Full Text] [Related]
3. Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007. Briesacher BA; Quittner AL; Fouayzi H; Zhang J; Swensen A Pediatr Pulmonol; 2011 Aug; 46(8):770-6. PubMed ID: 21465674 [TBL] [Abstract][Full Text] [Related]
4. Adherence to inhaled therapies over 4 years in people with cystic fibrosis. Manika K; Hatziagorou E; Kotoulas SC; Kyrvasili SS; Sourla E; Kouroukli E; Sionidou M; Papadaki E; Tsanakas J Pediatr Pulmonol; 2022 Apr; 57(4):956-964. PubMed ID: 35040288 [TBL] [Abstract][Full Text] [Related]
5. Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis. Nasr SZ; Chou W; Villa KF; Chang E; Broder MS J Med Econ; 2013; 16(6):801-8. PubMed ID: 23506540 [TBL] [Abstract][Full Text] [Related]
6. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128 [TBL] [Abstract][Full Text] [Related]
7. Economic impact of tobramycin in patients with cystic fibrosis in a managed care population. Wertz DA; Chang CL; Stephenson JJ; Zhang J; Kuhn RJ J Med Econ; 2011; 14(6):759-68. PubMed ID: 21942462 [TBL] [Abstract][Full Text] [Related]
8. Impact of home spirometry on medication adherence among adolescents with cystic fibrosis. Shakkottai A; Kaciroti N; Kasmikha L; Nasr SZ Pediatr Pulmonol; 2018 Apr; 53(4):431-436. PubMed ID: 29457700 [TBL] [Abstract][Full Text] [Related]
9. A five-year retrospective analysis of adherence in cystic fibrosis. Shakkottai A; Kidwell KM; Townsend M; Nasr SZ Pediatr Pulmonol; 2015 Dec; 50(12):1224-9. PubMed ID: 26346919 [TBL] [Abstract][Full Text] [Related]
10. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre. Heimeshoff M; Hollmeyer H; Schreyögg J; Tiemann O; Staab D Pharmacoeconomics; 2012 Sep; 30(9):763-77. PubMed ID: 22690685 [TBL] [Abstract][Full Text] [Related]
12. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Pittman DG; Chen W; Bowlin SJ; Foody JM Am J Cardiol; 2011 Jun; 107(11):1662-6. PubMed ID: 21439533 [TBL] [Abstract][Full Text] [Related]
13. Healthcare expenditures for privately insured people with cystic fibrosis. Ouyang L; Grosse SD; Amendah DD; Schechter MS Pediatr Pulmonol; 2009 Oct; 44(10):989-96. PubMed ID: 19768806 [TBL] [Abstract][Full Text] [Related]
14. Clustered randomized controlled trial of a clinic-based problem-solving intervention to improve adherence in adolescents with cystic fibrosis. Quittner AL; Eakin MN; Alpern AN; Ridge AK; McLean KA; Bilderback A; Criado KK; Chung SE; Riekert KA J Cyst Fibros; 2019 Nov; 18(6):879-885. PubMed ID: 31103533 [TBL] [Abstract][Full Text] [Related]
15. Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis. Durieu I; Dalon F; Reynaud Q; Lemonnier L; Dehillotte C; Bérard M; Walther D; Viprey M; Van Ganse E; Belhassen M J Cyst Fibros; 2022 Jan; 21(1):88-95. PubMed ID: 33865726 [TBL] [Abstract][Full Text] [Related]
16. Outcome evaluation of a pharmacy-based therapy management program for patients with cystic fibrosis. Kirkham HS; Staskon F; Hira N; McLane D; Kilgore KM; Parente A; Kim S; Sawicki GS Pediatr Pulmonol; 2018 Jun; 53(6):720-727. PubMed ID: 29512893 [TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population. Mattke S; Martorell F; Hong SY; Sharma P; Cuellar A; Lurie N J Asthma; 2010 Apr; 47(3):323-9. PubMed ID: 20394518 [TBL] [Abstract][Full Text] [Related]
18. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. Tan X; Al-Dabagh A; Davis SA; Lin HC; Balkrishnan R; Chang J; Feldman SR Am J Clin Dermatol; 2013 Jun; 14(3):243-51. PubMed ID: 23572294 [TBL] [Abstract][Full Text] [Related]
19. Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators. Sun P; Peng X; Sun S; Novick D; Faries DE; Andrews JS; Wohlreich MM; Wu A Pain Pract; 2014 Jan; 14(1):22-31. PubMed ID: 23489659 [TBL] [Abstract][Full Text] [Related]
20. Understanding the costs of care for cystic fibrosis: an analysis by age and health state. van Gool K; Norman R; Delatycki MB; Hall J; Massie J Value Health; 2013; 16(2):345-55. PubMed ID: 23538187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]